Provided by Tiger Trade Technology Pte. Ltd.

Shattuck Labs, Inc.

7.53
+0.28003.86%
Pre-market: 7.530.00000.00%04:01 EDT
Volume:475.59K
Turnover:3.52M
Market Cap:755.74M
PE:-15.03
High:7.55
Open:7.35
Low:7.25
Close:7.25
52wk High:8.33
52wk Low:0.9000
Shares:100.36M
Float Shares:67.76M
Volume Ratio:0.82
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5010
EPS(LYR):-0.7014
ROE:-39.21%
ROA:-24.43%
PB:3.58
PE(LYR):-10.74

Loading ...

Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8

GlobeNewswire
·
Jun 06

Shattuck Labs Raised to Buy From Neutral by Citigroup

Dow Jones
·
Jun 06

Citigroup Upgrades Shattuck Labs to Buy From Neutral, Price Target is $7

MT Newswires Live
·
Jun 05

Shattuck Labs Inc : Citigroup Raises to Buy From Neutral

THOMSON REUTERS
·
Jun 05

Citi opens ‘upside 30-day catalyst watch’ on Shattuck into data

TIPRANKS
·
Jun 05

Shattuck Labs upgraded to Buy from Neutral at Citi

TIPRANKS
·
Jun 05

Shattuck Labs Shareholders Approve Directors, Compensation, Governance Measures

TIPRANKS
·
Jun 03

Shattuck Labs shareholders approve amended 2020 equity incentive plan, adding 1,691,082 shares

Reuters
·
Jun 03

Shattuck Labs CTO Abhinav Shukla disposes 2,032 shares worth $14,244.32

Reuters
·
May 15

Shattuck Labs CMO Arundathy Pandite sells 30,000 shares for $198,300

Reuters
·
May 15

Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK), Novavax (NVAX) and Airsculpt Technologies (AIRS)

TIPRANKS
·
May 10

Shattuck Labs Is Maintained at Outperform by Wedbush

Dow Jones
·
May 08

Wedbush Raises Price Target on Shattuck Labs to $11 From $8, Keeps Outperform Rating

MT Newswires Live
·
May 08

SL-325 Data Catalysts and Phase 2 Launch Plans Underpin Buy Rating on Shattuck Labs

TIPRANKS
·
May 08

Shattuck Labs reports Q1 EPS (13c), consensus (13c)

TIPRANKS
·
May 08

Shattuck Labs sees cash and cash equivalents sufficient into 2029

TIPRANKS
·
May 08

Shattuck Labs posts corporate deck outlining DR3 antibody SL-325 for inflammatory diseases

Reuters
·
May 07

Shattuck Labs Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Shattuck Labs Q1 EPS $(0.13), Inline

Benzinga Earnings
·
May 07

BRIEF-Shattuck Labs Q1 Net Income USD -14.767 Million

Reuters
·
May 07